Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors
about
Future directions: lung aging, inflammation, and human immunodeficiency virusJoint modeling of HIV data in multicenter observational studies: A comparison among different approaches.Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infection.Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialImmunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort StudyEvaluation of immunological indices in HIV-infected patients with chronic hepatitis C in Kazakhstan.Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationIncreased expression of intrinsic antiviral genes in HLA-B*57-positive individualsHIV infection is associated with diffusing capacity impairment in womenBlunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaborationUnderstanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.Analysis of Non-AIDS-Defining Events in HIV Controllers.Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.CD4/CD8 ratio is a promising candidate for non-invasive measurement of liver fibrosis in chronic HCV-monoinfected patients.Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature.Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals.Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.
P2860
Q26996040-AED5A512-31F0-4400-A041-EF1C2E676E83Q30786463-22AC8A79-D1C5-4245-9A67-B2BBFF394681Q34340862-C51F3A1D-9D8A-469D-BC0D-2DDD50C16B74Q34611671-8FCF1F50-3C38-480C-B37B-1472C6A0C6BCQ35124927-9E4ECEDB-55BB-4CE6-B4D1-088A8F7C26EBQ35683067-A7F2F283-0188-4C8E-AA79-169DAF9344F3Q35814594-35F7E138-5D3A-4306-B4C4-E5F01EA3688CQ36944118-259F7B37-B3C0-4718-9C49-C4032145D9B5Q37031810-A6EB3349-D3E3-4959-98F1-8DE2655E26A6Q37238299-B41DC3E8-4EC3-4982-B6E6-11E1C051D098Q37378469-D055C8CF-CA0D-48BB-B901-706F9B9D1AF5Q37490654-212E8B42-1D76-407C-A5DD-2765F56722EFQ38066127-BCA7FD59-C729-4089-AC5B-66371A9A1826Q38180719-AEC1D192-AE26-43F4-931F-104654C98B86Q38900456-31EF8952-6E6D-4BC9-8B64-1426C93E0B8CQ39952253-2F8BD614-3D75-42A9-8F49-A4995DD71556Q40109601-F7F721E9-D1EC-4536-B554-9AA513623084Q40142539-63670DC0-9E08-4920-9A77-A028353EC589Q42232000-4BC45C46-6429-42E9-AC79-59ECF9A57F96Q47170671-A3D31037-73FD-4D91-A7BE-676AA1F47FC6Q47568945-5E2641F2-4DCC-42E5-9A58-C4E076CBDF6DQ47693953-1DA7F602-FC4C-4A60-871B-341275CAEE45Q52680990-79DB272A-3BA6-489B-8826-48A756B6046E
P2860
Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic immune activation and ...... IV-1 natural viral suppressors
@en
Chronic immune activation and ...... V-1 natural viral suppressors.
@nl
type
label
Chronic immune activation and ...... IV-1 natural viral suppressors
@en
Chronic immune activation and ...... V-1 natural viral suppressors.
@nl
prefLabel
Chronic immune activation and ...... IV-1 natural viral suppressors
@en
Chronic immune activation and ...... V-1 natural viral suppressors.
@nl
P2093
P2860
P1433
P1476
Chronic immune activation and ...... IV-1 natural viral suppressors
@en
P2093
Mohammad M Sajadi
Robert R Redfield
Rohit Talwani
Roopa Pulijala
P2860
P304
P356
10.1097/QAD.0B013E328357F5D1
P407
P577
2012-09-01T00:00:00Z